Health
CREB1: A Potential Target for Treating Pancreatic Cancer – Technology Networks
Preclinical research using cell lines, genetic mouse models and human pancreatic tumor tissue samples has identified the transcription factor CREB1 as a potential…
Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumor tissue identified the transcription factor CREB1 (for cyclic AMP-responsive element binding protein 1) as a potential therapeutic target for the treatment of pancreatic cancer, according to results presented during Week 1 of the virtual AACR Annual Meeting 2021, held April 10-15. This study is being simultaneously published in Cancer Discovery, a journal of the American Association for Cancer Research.
Pancreatic…
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
General20 hours agoFire razes Tumby Bay hardware store with damage likely to exceed $1m
-
Noosa News5 hours agoExcellence awards nominations received – Proctor
-
Business8 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025